...
首页> 外文期刊>Preventive Veterinary Medicine >Validation of an indirect immunofluorescence assay (IFA) for the detection of IgG antibodies against Coxiella burnetii in bovine serum
【24h】

Validation of an indirect immunofluorescence assay (IFA) for the detection of IgG antibodies against Coxiella burnetii in bovine serum

机译:验证对牛血清中Coxiella Burnetii的IgG抗体检测的间接免疫荧光测定法(IFA)

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

There is limited knowledge of the true prevalence and distribution of coxiellosis in dairy and beef cattle populations in Australia. For this to occur, apparent prevalence estimates need to be reliably adjusted, accounting for diagnostic sensitivity (DSe) and diagnostic specificity (DSp) of the test used. However, there are few tests available with known diagnostic specifications suitable to inform screening and surveillance activities in the Australian context. We initially modified and optimised a human indirect immunofluorescence assay (IFA) test for the detection of IgG antibodies against phase I and/or phase II Coxiella burnetii in bovine sera and determined an optimal screening dilution cut-off to be 1:160. Direct comparison of the modified IFA with the commercial IDEXX enzyme-linked immunosorbent assay (ELISA) kit (Q Fever Ab Test IDEXX Laboratories, United States of America) was performed by testing 458 serum samples from four distinct cattle populations across the east coast of Australia and New Zealand. Cross classified test results were then analysed using Bayesian latent class modelling, to validate the tests in the absence of a gold standard reference test. Results from this analysis indicate that the IFA, at a 1:160 serum dilution, has an estimated DSe of 73.6% (95% Credible Interval (CrI) 61.1, 85.9) and DSp of 98.2% (95% CrI 95.1, 99.7). The commercial IDEXX ELISA kit was found to have a higher DSe of 87.9% (95% CrI 73.9, 96.4) and similar DSp of 97.7% (95% CrI 93.2, 99.7). Evaluation of the diagnostic performance of the IFA and ELISA methods, specifically for use in cattle will enable more accurate interpretation of prevalence estimates of C. burnetii exposure to be reported for cattle in Australia and other countries.
机译:了解澳大利亚乳制品和牛肉牛群的真正患病率和分布的真正患病率和分布。为此,需要可靠地调整表观患病率估计,核算用于所使用的测试的诊断敏感性(DSE)和诊断特异性(DSP)。但是,有很少的测试可用于已知的诊断规范,适合于澳大利亚背景下的筛选和监视活动。我们首先改性和优化了人们间接免疫荧光测定(IFA)试验,用于检测牛血清中II和/或II型Coxiella Burnetii的IgG抗体,并确定最佳的筛选稀释截止值为1:160。通过在澳大利亚东海岸的四个不同的牛群中测试458个血清样本来进行改性IDA与商业IDEXX酶联免疫吸附试验(ELISA)试剂盒(Q发热AB测试IDEXX实验室)的直接比较。和新西兰。然后使用贝叶斯潜类建模分析交叉分类测试结果,以验证在没有金标准参考测试的情况下进行测试。该分析的结果表明IFA,在1:160血清稀释,估计DSE为73.6%(95%可信间隔(CRI)61.1,85.9)和DSP为98.2%(95%CRI 95.1,99.7)。发现商业IDEXX ELISA试剂盒具有87.9%(95%CRI 73.9,96.4)和97.7%的类似DSP(95%CRI 93.2,99.7)。评估IFA和ELISA方法的诊断性能,专门用于牛的方法将使澳大利亚和其他国家的牛的牛报告C. BurneTii暴露的患病率估计更准确地解释。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号